Correlation between Arterial Lactate and Central Venous Lactate in Children with Sepsis

Jaime Fernández Sarmiento1, Paula Araque2, María Yepes2

  • 1Pediatric Critical Care Department, Fundación Cardioinfantil, Universidad de la Sabana, Bogotá, Colombia.

Insights

Arterial and central venous lactate measurements show a strong correlation in pediatric sepsis patients. This finding is consistent across different ages and vasoactive drug use, simplifying monitoring for critically ill children.

Area of Science:

  • Pediatric Critical Care Medicine
  • Biomedical Monitoring
  • Sepsis Pathophysiology

Background:

  • Lactate is a key biomarker for assessing tissue perfusion and guiding treatment in sepsis.
  • Accurate lactate measurement is crucial for managing pediatric sepsis and septic shock.
  • Understanding the agreement between arterial and central venous lactate is important for clinical practice.

Purpose of the Study:

  • To determine if significant differences exist between arterial and central venous lactate measurements in pediatric patients diagnosed with sepsis or septic shock.
  • To evaluate the correlation between simultaneous arterial and central venous lactate levels.

Main Methods:

  • A longitudinal retrospective observational study design was employed.
  • Data were collected from 42 pediatric patients (1 month to 17 years) with sepsis/septic shock admitted to the ICU.
  • Simultaneous arterial and central venous lactate samples were drawn within 24 hours of admission.

Main Results:

  • A strong positive correlation (Spearman's Rho = 0.872, p < 0.001) was observed between arterial and venous lactate levels.
  • This correlation remained significant after adjusting for patient age (p < 0.05).
  • The correlation was also unaffected by the use of vasoactive drugs (p < 0.05).

Conclusions:

  • Arterial and central venous lactate measurements are highly correlated in pediatric patients with sepsis and septic shock.
  • This agreement is robust and not influenced by demographic factors or hemodynamic support.
  • The findings suggest that either arterial or central venous lactate can be reliably used for monitoring in this patient population.